Blood Bags Market

Market Overview:

The global blood bags market size reached US$ 265.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 443.2 Million by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.

A blood bag is used for the transfer, collection, storage, and transfusion of blood and its components, including platelets, plasma, and cryoprecipitate. It is generally manufactured from bio-compatible PVC materials and is integrated with collection tubes, needles, needle covers, and clamps. Blood bags are mostly available in the form of Citrate Phosphate Dextrose Adenine (CPDA) blood bags, Saline Adenine Glucose Mannitol (SAGM) blood bags, and transfer bags. Based on various transfusion types, they can be further classified into single, double, triple, and quadruple blood collection bags. These bags are widely adopted across surgery centers, trauma centers, emergency units, ambulatory facilities, intensive care units, etc.

Blood Bags Market Trends:

The global blood bags market is primarily driven by the rising incidences of fatal accidents along with the wide presence of trauma centers across the world. According to estimates by the World Health Organization, nearly 1.4 million people die each year because of road traffic crashes. Moreover, the high prevalence of several blood-related medical ailments, such as anemia, hemophilia, myeloma, leukemia, etc., is also driving the demand for blood transfusion. Numerous invasive surgical procedures in the field of cardiology, neurology, orthopedics, oncology, etc., are further catalyzing this market for blood bag. Moreover, the rising investments in healthcare infrastructure development are also propelling the establishment of blood banks, medical research laboratories, and diagnostic centers. The introduction of several blood donation programs by various government bodies and non-profit organizations is also augmenting the market for blood bags.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood bags market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application, end user, material and capacity.

Breakup by Product Type:

• Single Blood Bag
• Double Blood Bag
• Triple Blood Bag
• Quadruple Blood Bag
• Penta Blood Bag
   

Breakup by Application:

• Collection Blood Bag
• Transfer Blood Bag
   

Breakup by End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Blood Banks
• Others
   

Breakup by Material:

• Poly Vinyl Chloride Blood Bag
• Polyethylene Terephthalate Blood Bag
• Others
   

Breakup by Capacity:

• 100ml Blood Bag
• 150ml Blood Bag
• 250ml Blood Bag
• 300ml Blood Bag
• 350ml Blood Bag
• 400ml Blood Bag
• 450ml Blood Bag
• 500ml Blood Bag
   

Breakup by Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Others
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Others
• Middle East and Africa
  • Turkey
  • South Africa
  • Saudi Arabia
  • UAE
  • Others
     

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being AdvaCare Pharma, BL Life Sciences Pvt. Ltd, Demophorius Healthcare Ltd., Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, Innvol Medical India Limited, JMS Co. Ltd., Kawasumi Laboratories Inc., Maco Pharma International GmbH, Mitra Industries Pvt. Ltd., Neomedic Limited, Poly Medicure Ltd., Span Healthcare Private Limited, Suru International Private Ltd., Teleflex Incorporated, Terumo Corporation, The Metric Company and Troge Medical GmbH.

Report Coverage: